
1. obstet gynecol. 1989 nov;74(5):800-8.

review human immunodeficiency virus infection women united states.

shapiro cn(1), schulz sl, lee nc, dondero tj.

author information: 
(1)center infectious diseases, centers disease control, atlanta, georgia.

in review, available human immunodeficiency virus (hiv) seroprevalence data 
are presented united states women attending clinics related reproductive
health women settings. family planning clinics, prenatal
clinics, delivery room settings (cord blood testing), studies have
not targeted women high risk hiv infection shown prevalence rates
ranging 0-4.3%. higher rates (greater 1%) observed more
urban areas--newark, new york city, baltimore, miami, san juan; rates at
settings outside areas generally 1%. filter-paper testing
for maternal hiv antibodies neonatal heel-stick specimens conducted
statewide massachusetts new york; prevalence rates 0.3% in
massachusetts 1987, 0.2% upstate new york 1.3% new york city 
1987-1988. prevalence rates female military applicants female blood donors
are 0.03% 0.1%, respectively, relatively stable over
time. age data available, prevalence rates near 0 women below
age 20 years, higher young adult early middle-aged women, decline
thereafter. studies also conducted using blood samples women
undergoing premarital testing syphilis serology, women attending
sexually transmitted disease clinics drug treatment centers, from
patients sentinel hospital sites. information prevalence hiv
infection united states women useful identify specific populations at
risk hiv infection target evaluate education prevention
efforts.


pmid: 2682415  [indexed medline]

